The FDA has recalled nearly 40 life-saving generics produced by Glenmark Pharmaceuticals, citing concerns over faulty manufacturing practices. Initially recalled on March 13, the agency classified the risk level as Class II, suggesting potential for temporary or reversible health effects. Many of the affected medications treat serious conditions including epilepsy, heart disease, and diabetes. While experts indicate a lack of expectation for serious illness from the recall, patients are advised to consult healthcare providers regarding their use of the affected drugs, especially those widely dispensed through major retailers like Amazon and Walmart.
Patients using any of the 39 recalled medications are advised to contact their pharmacist, physician or medical provider to discuss next steps.
The FDA gave the recall a Class II risk level on April 8, which is defined as a product that could cause temporary or medically reversible health effect.
The federal agency noted that the production was in violation of their Current Good Manufacturing Practice standards - rules that ensure medications are made safely and consistently.
As of now, experts do not expect the recalled tablets to cause any serious illnesses or death in patients.
Collection
[
|
...
]